Amendment #0001 | Overlapping Peptide Library of Rabies Envelope Glycoprotein and HPV (L1) Capsid L1 Protein

Closed Solicitation Posted

Solicitation number
75N91023Q00144
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
United States

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institutes of Health (NIH), National Cancer Institute (NCI), Laboratory of Cellular Oncology (LCO) is seeking a contractor to design, synthesize, purify, analyze, pool, and test overlapping peptides of the rabies envelope glycoprotein and HPV capsid L1 protein. The peptides will be used to evaluate the biologic and therapeutic potential of Viral Peptide Libraries (VPLs) for cancer treatment. The contractor is expected to deliver the peptides within seven weeks of receipt of order.

Products and Services:

  1. Design of overlapping peptide sequences for HPV16-vcpL1 and Rabies-gpENV.
  2. Synthesis, purification, and analysis of the designed peptides.
  3. Pooling and testing of the synthesized peptides.
  4. Delivery of aliquots of pooled peptides and individual peptides.
  5. Peptide testing including bacterial endotoxin testing, bioburden test, and determination of residual acetonitrile solvent, water content, and potential residual counter ions.

Notice text

2 versions

Update #2 · Latest ·

See attached combined synopsis solicitation that includes instructions on how to submit quotes for any interested offeror. 

Amendment #0001 - RFQ Response date is hereby extended until 08/31/2023.

Update #1 ·

See attached combined synopsis solicitation that includes instructions on how to submit quotes for any interested offeror. 

Files

File Type Posted
FAR 52.212-3 DEC 2022.pdf PDF
NCI_RFQ_Q00144_Amendment 0001.pdf PDF
NCI RFQ_75N91023Q00144.pdf PDF

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors